The clinical importance of medulloblastoma extent of resection: a systematic review
- 23 May 2018
- journal article
- review article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 139 (3) , 523-539
Abstract
Although the majority of current medulloblastoma adjuvant therapy protocols treat patients with ≥ 1.5 cm2 residual tumor as high risk with increased craniospinal irradiation, the true prognostic significance of extent of resection (EOR) in medulloblastoma is unknown.Keywords
This publication has 71 references indexed in Scilit:
- Hyperfractionated Versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 TrialJournal of Clinical Oncology, 2012
- Long Time to Diagnosis of Medulloblastoma in Children Is Not Associated with Decreased Survival or with Worse Neurological OutcomePLOS ONE, 2012
- Molecular subgroups of medulloblastoma: the current consensusActa Neuropathologica, 2011
- Medulloblastoma Variants: Age-Dependent Occurrence and Relation to Gorlin Syndrome—A New Clinical PerspectiveClinical Cancer Research, 2009
- Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk MedulloblastomaJournal of Clinical Oncology, 2006
- Neurocognitive Consequences of Risk-Adapted Therapy for Childhood MedulloblastomaJournal of Clinical Oncology, 2005
- C-MYC expression in medulloblastoma and its prognostic valueInternational Journal of Cancer, 2000
- Improving Survival of Medulloblastoma: Results in Two Groups of PatientsOncology, 1996
- MeduUoblastoma with Brain Stem Involvement: The Impact of Gross Total Resection on OutcomePediatric Neurosurgery, 1996
- Medulloblastoma in childrenJournal of Neurosurgery, 1977